鷹架技術市場報告：2030 年趨勢、預測與競爭分析

支架技術趨勢與預測

全球支架技術市場的未來前景廣闊，為生物技術和製藥公司、合約實驗室和學術機構市場提供了機會。預計2024年至2030年全球鷹架技術市場將以17.8%的複合年成長率成長。該市場的主要驅動力是對身體重組手術和組織工程的需求不斷成長、生物材料使用的擴大以及支架技術的進步。

• 根據應用，Lucintel 預測，癌症細胞研究將成為預測期內最大的部分，因為癌症發生率的增加正在推動新型癌症預防和治療策略的發展。
• 在最終用途類別中，學術機構將繼續是最大的部分，因為支架技術廣泛應用於牙周再生和軟骨合成等組織工程領域。
• 從地區來看，由於癌症患者的快速增加、器官移植的增加以及生物技術和製藥公司的擴張，北美在預測期內可能仍然是最大的地區。

支架技術市場的策略成長機會

支架技術市場在關鍵應用領域存在一些策略性成長機會。透過利用這些機會，我們可以促進創新並擴大支架技術在再生醫學中的使用。

• 再生醫學：支架技術在再生醫學的應用具有巨大的成長潛力。支架透過提供結構支撐和促進細胞生長，在組織修復和器官再生中發揮重要作用。開發先進的再生醫學支架可以解決未滿足的醫療需求並推動市場擴張。
• 整形外科應用：支架技術為骨骼修復和軟骨再生等整形外科應用提供了成長機會。具有增強機械性能和生物相容性的先進支架可以支持骨折和軟骨損傷的癒合，並改善整形外科治療中的患者預後。
• 人工植牙在牙科領域，支架技術正在推動牙科修復植入和組織工程解決方案的開發。專為牙科應用而設計的支架可以改善植入的完整性和功能，支持更好的口腔健康治療效果，並擴大牙科支架技術的市場。
• 創傷治療：支架技術在創傷治療應用中具有巨大潛力。開發促進細胞遷移和組織再生的支架可以增強慢性傷口和燒燙傷的治療。支架設計和材料的創新將改善創傷治療效果並促進該領域的發展。
• 藥物輸送系統：支架也被考慮應用於藥物輸送系統。將治療劑摻入支架中可提供受控和局部的藥物釋放，從而增強治療效果。該應用為開發具有改進的靶向性和功效的先進藥物輸送解決方案提供了成長機會。

支架技術市場的策略性成長機會包括再生醫學、整形外科、人工植牙、創傷治療和藥物傳輸系統等應用。這些機會提供了創新和擴展的潛力，促進了先進支架技術在各個醫療領域的開發和採用。

支架技術市場促進因素與挑戰

支架技術市場受到材料科學進步、再生醫學需求增加、研究投資增加、監管動態和市場競爭的推動和挑戰。了解這些因素對於駕馭市場並克服支架技術成長和創新的障礙至關重要。

推動鷹架技術市場的因素是：

• 技術進步：3D 列印、奈米技術和智慧材料正在徹底改變支架技術。這些創新改善了支架功能、客製化特性和整體性能，增強了組織再生並開啟了新的可能性。
• 對再生醫學的需求不斷增加：對再生醫學和組織工程的日益關注正在推動對更複雜的支架解決方案的需求。支架在支持組織修復和器官再生方面發揮重要作用，有助於治療複雜的病理和損傷。
• 增加研發投入：創新研發的投資正在推動鷹架開發產業的變革。私人企業、政府機構和研究機構加大對新材料、新技術和應用開發的支持正在推動市場擴張。
• 意識和醫療保健需求的提高：人們對支架益處的認知不斷提高，再生療法不斷增加，正在推動市場成長。隨著醫療保健需求的不斷發展，需要能夠靈活應對各種醫療狀況的先進支架解決方案。
• 對創新的監管支援：監管機構在創造進步的法規環境以促進支架相關新技術的引入方面發揮重要作用。這樣的環境創造了快速進入市場的途徑，並支援先進鷹架解決方案的開發。

支架技術市場的挑戰包括：

• 先進技術的高成本：與先進支架技術（例如專用材​​料和製造流程）相關的高成本使許多人難以獲得並限制了這些解決方案的採用。對於價格敏感的市場，先進的鷹架可能難以負擔，從而限制了它們的使用。
• 支架設計和製造的複雜性：支架設計和製造需要組織工程和材料科學專業知識。這些過程通常很複雜，這使得確保每個鷹架在製造過程中耐用、可靠且功能齊全成為品質挑戰。這些問題降低了基於支架的治療的效率。

技術進步、再生醫學需求的增加、研發活動的投資、醫療需求的增加以及監管支持是推動支架技術市場的因素。然而，高成本、設計複雜性、監管障礙和結果不一致等挑戰仍然存在，需要專注於促進該領域的成長和創新。

目錄

第1章執行摘要

第2章全球支架技術市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球支架技術市場趨勢（2018-2023）與預測（2024-2030）
• 全球支架技術市場：依產品
  • 天然支架
  • 合成支架
• 全球支架技術市場：按類型
  • 大孔支架
  • 微孔支架
  • 奈米多孔支架
  • 固體的鷹架
• 全球鷹架技術市場：依應用分類
  • 藥物發現
  • 再生醫學
  • 癌細胞研究
  • 幹細胞研究
• 全球支架技術市場：依最終用途分類
  • 生物技術和製藥公司
  • 合約調查機構
  • 學術機構

第4章 2018-2030年區域市場趨勢及預測分析

• 全球鷹架技術市場：按地區
• 北美支架技術市場
• 歐洲支架技術市場
• 亞太地區支架技術市場
• 其他地區鷹架技術市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球支架技術市場按產品分類的成長機會
  • 按類型分類的全球支架技術市場成長機會
  • 全球支架技術市場應用的成長機會
  • 按最終用途分類的全球支架技術市場成長機會
  • 全球支架技術市場區域成長機會
• 全球鷹架技術市場的新興趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球支架技術市場的產能
  • 全球支架技術市場的合併、收購和合資企業
  • 認證和許可

第7章主要企業概況

• Synthecon
• Bico
• Lonza
• Thermo Fisher Scientific
• Avantor
• ReproCELL
• 3D Biotek
• Corning
• Becton, Dickinson, &Company
• InSphero

Scaffold Technology Trends and Forecast

The future of the global scaffold technology market looks promising with opportunities in the biotechnology & pharmaceutical company, contract research laboratory, and academic institute markets. The global scaffold technology market is expected to grow with a CAGR of 17.8% from 2024 to 2030. The major drivers for this market are increasing demand for procedures in body reconstruction and tissue engineering, growing utilization of biomaterials, as well as, advancements in scaffold technology.

• Lucintel forecasts that, within the application category, cancer cell research will remain the largest segment over the forecast period due to an increase in cancer incidence that has prompted the creation of novel cancer prevention and treatment strategies.
• Within the end-use category, academic institutes will remain the largest segment because the scaffold technology is widely employed in tissue engineering domains like periodontal regeneration and cartilage synthesis.
• In terms of regions, North America will remain the largest region over the forecast period due to a surge in cancer cases, growth in organ transplantations, and expansion of biotechnology and pharmaceutical firms.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Scaffold Technology Market

The scaffold technology market is experiencing several emerging trends that reflect advancements in materials science, fabrication techniques, and clinical applications. These trends are reshaping the landscape of tissue engineering and regenerative medicine.

• 3D Bioprinting: The use of 3D bioprinting technology is revolutionizing scaffold production by enabling precise and customizable scaffold designs. With this trend, complex, patient-specific structures can be created to improve tissue regeneration or repair. Additionally, bioprinting allows the incorporation of multiple cell types and growth factors within scaffolds, enhancing their functionality.
• Smart Scaffolds: Smart scaffolds that respond to environmental stimuli, such as changes in pH or temperature, are gaining traction. These materials can adapt to biological conditions, facilitating controlled drug release or specific cellular responses. This makes scaffold-based therapy more effective and further supports dynamic tissue regeneration.
• Nanotechnology Integration: Incorporating nanotechnology into scaffold design is improving material properties and performance. Nanomaterials enhance strength, porosity, biocompatibility, and cell integration, which contribute to better tissue formation within the scaffolds. They also enable the development of special functions, such as antimicrobial properties and enhanced cell interactions, for use in specific types of scaffolds.
• Regenerative Medicine Applications: Scaffold technology is increasingly being applied in regenerative medicine, such as tissue engineering and organ regeneration. The application of advanced biomaterials and scaffold designs has led to the formation of functional tissues and organs, which can be used to treat complex diseases or injuries.
• Personalized Medicine: The shift toward personalized medicine has resulted in a growing demand for customized scaffolds made specifically for individuals. Innovations in 3D scanning and bioprinting technologies have led to the development of tailor-made scaffolds that match a patient's bodily structure, thereby improving treatment outcomes and patient satisfaction.

Emerging trends in the scaffold technology market, including 3D bioprinting, smart materials, biodegradable scaffolds, hybrid scaffolds, and personalized medicine, are advancing the field of tissue engineering. These trends are driving innovation, improving scaffold functionality, and expanding applications in regenerative medicine, ultimately enhancing treatment outcomes and patient care.

Recent Developments in the Scaffold Technology Market

Recent developments in the scaffold technology market highlight significant advancements in materials, fabrication techniques, and clinical applications. These developments are advancing the field of tissue engineering and regenerative medicine.

• Advancements in 3D Bioprinting: The development of three-dimensional (3D) bioprinting has revolutionized scaffold production, enabling highly tailored designs of intricate structures. This means biological architectures, including pore size and spatial cell distribution, can now be precisely controlled, facilitating better tissue integration and regeneration. Bioprinting allows individual patient needs to be met, resulting in personalized scaffolds.
• Development of Smart Scaffolds: Scaffold technology has become smarter by introducing responsive properties that help scaffolds adapt to physiological changes. These smart scaffolds are constructed using materials that can change their characteristics under environmental conditions, such as pH or temperature variations. This innovation allows dynamic treatment approaches, such as controlled drug delivery or live monitoring of tissue development.
• Integration of Nanotechnology: Nanotechnology enhances various material features at the nanoscale, improving scaffold design. Nanomaterials incorporated into the scaffold improve strength, biocompatibility, and cellular interactions. Furthermore, scaffolds can now be developed with additional functionalities, such as antimicrobial properties, which contribute significantly to overall treatment outcomes.
• Focus on Biodegradable Materials: Recent developments have focused on using biodegradable materials in scaffold technology. Biodegradable scaffolds eliminate the need for secondary surgeries, thus reducing long-term complications and supporting natural tissue growth. Advances in biodegradable polymers and composites have increased the efficacy and safety of scaffold-based treatments.
• Increased Research in Regenerative Medicine: More studies are being conducted on integrating scaffold technology into regenerative medicine applications. Significant innovations include combining scaffolds with stem cells and growth factors, leading to tissue repair or regeneration. This has opened up prospects for functional tissue or organ replacements to address complex medical conditions or injuries.

Recent developments in the scaffold technology market, including advancements in 3D printing, biomaterials, regulatory frameworks, manufacturing techniques, and collaborative research, are driving innovation and improving the field of tissue engineering. These developments enhance scaffold functionality, support regulatory compliance, and expand the potential applications of scaffold technologies.

Strategic Growth Opportunities for Scaffold Technology Market

The scaffold technology market presents several strategic growth opportunities across key applications. Capitalizing on these opportunities can drive innovation and expand the use of scaffold technologies in regenerative medicine.

• Regenerative Medicine: The application of scaffold technology in regenerative medicine offers significant growth potential. Scaffolds play a crucial role in tissue repair and organ regeneration by providing structural support and promoting cell growth. Developing advanced scaffolds for regenerative medicine can address unmet medical needs and drive market expansion.
• Orthopedic Applications: Scaffold technology presents growth opportunities in orthopedic applications, such as bone repair and cartilage regeneration. Advanced scaffolds with enhanced mechanical properties and biocompatibility can support the healing of bone fractures and cartilage injuries, improving patient outcomes in orthopedic treatments.
• Dental Implants: In the dental field, scaffold technology is advancing the development of implants and tissue engineering solutions for dental repairs. Scaffolds designed for dental applications can improve the integration and functionality of implants, supporting better outcomes in oral health treatments and expanding the market for dental scaffold technologies.
• Wound Healing: Scaffold technology has significant potential in wound healing applications. Developing scaffolds that promote cell migration and tissue regeneration can enhance the treatment of chronic wounds and burns. Innovations in scaffold design and materials can improve wound healing outcomes and drive growth in this segment.
• Drug Delivery Systems: Scaffolds are also being explored for use in drug delivery systems. Incorporating therapeutic agents into scaffolds allows for controlled and localized drug release, enhancing treatment efficacy. This application offers growth opportunities in developing advanced drug delivery solutions with improved targeting and effectiveness.

Strategic growth opportunities in the scaffold technology market include applications in regenerative medicine, orthopedics, dental implants, wound healing, and drug delivery systems. These opportunities offer potential for innovation and expansion, driving the development and adoption of advanced scaffold technologies in various medical fields.

Scaffold Technology Market Driver and Challenges

The scaffold technology market is driven and challenged by advancements in material science, increasing demand for regenerative medicine, rising research investments, regulatory dynamics, and market competition. To navigate the market and overcome hurdles to growth and innovation in scaffold technology, it is important to understand these factors.

The factors responsible for driving the scaffold technology market include:

• Technological Advancements: 3D printing, nanotechnology, and smart materials are revolutionizing scaffold technology. These innovations have improved scaffold functionality, customization properties, and overall performance, which has enhanced tissue regeneration and opened up new possibilities.
• Increasing Demand for Regenerative Medicine: The increasing emphasis on regenerative medicine and tissue engineering has fueled the demand for more sophisticated scaffold solutions. Scaffolds play an essential role in supporting tissue repair and organ regeneration, which help in treating complex medical conditions and injuries.
• Rising Investment in Research and Development: Investment in innovative research is promoting changes in the scaffold development industry. There is increased support from private companies, governmental organizations, and research institutions toward developing new materials, technologies, and applications, thereby facilitating market expansion.
• Growing Awareness and Healthcare Needs: Increasing awareness of the benefits of scaffolding, along with rising incidences of regenerative therapies, are propelling market growth. Advanced scaffold solutions are needed to flexibly address different medical conditions, as healthcare needs continue to evolve.
• Regulatory Support for Innovation: Regulatory bodies play a crucial role in creating advanced regulatory environments that encourage the introduction of new technologies related to scaffolds. These environments help create fast pathways to market entry, thus supporting the development of advanced scaffold solutions.

Challenges in the scaffold technology market include:

• High Costs of Advanced Technologies: High costs associated with advanced scaffold technologies, including specialized materials and manufacturing processes, make it difficult for many to access these solutions, limiting their adoption rates. Price-sensitive markets may find advanced scaffolds unaffordable, thus limiting their availability.
• Complexity of Scaffold Design and Production: Designing and producing scaffolds requires expertise in tissue engineering and materials science. These processes are often complex, and ensuring that each scaffold is durable, reliable, and functional during manufacturing poses quality challenges. These issues can reduce the efficiency of scaffold-based treatments.

Advances in technology, increased demand for regenerative medicine, investment in R&D activities, growing healthcare needs, and regulatory support are some of the factors driving the scaffold technology market. However, challenges such as high costs, design complexity, regulatory hurdles, and inconsistent outcomes remain, requiring attention to drive growth and innovation in the sector.

List of Scaffold Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies scaffold technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the scaffold technology companies profiled in this report include-

• Synthecon
• Bico
• Lonza
• Thermo Fisher Scientific
• Avantor
• ReproCELL
• 3D Biotek
• Corning
• Becton, Dickinson, &Company
• InSphero

Scaffold Technology by Segment

The study includes a forecast for the global scaffold technology by product type, type, application, end use, and region.

Scaffold Technology Market by Product Type [Analysis by Value from 2018 to 2030]:

• Natural Scaffold
• Synthetic Scaffold

Scaffold Technology Market by Type [Analysis by Value from 2018 to 2030]:

• Macro-Porous Scaffolds
• Micro-Porous Scaffolds
• Nano-Porous Scaffolds
• Solid Scaffolds

Scaffold Technology Market by Application [Analysis by Value from 2018 to 2030]:

• Drug Discovery
• Regenerative Medicine
• Cancer Cell Research
• Stem Cell Research

Scaffold Technology Market by End Use [Analysis by Value from 2018 to 2030]:

• Biotechnology & Pharmaceutical Companies
• Contract Research Laboratories
• Academic Institutes

Scaffold Technology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Scaffold Technology Market

Scaffold technology is crucial for tissue engineering and regenerative medicine, offering innovative solutions for repairing or replacing damaged tissues and organs. Recent advancements reflect the growing emphasis on improving biomaterials, fabrication techniques, and clinical applications across different regions. Below is an overview of recent developments in the scaffold technology market in the United States, China, Germany, and India.

• United States: Recent developments in the U.S. scaffold technology market include advancements in 3D bioprinting and personalized scaffolds. Research is focused on 3D printing patient-specific scaffolds to enhance tissue regeneration. Additionally, there is ongoing work to incorporate smart biomaterials into scaffolds, enabling them to sense biological signals and improving their functionality in regenerative medicine.
• China: In China, the scaffold technology market is experiencing growth driven by increased investment in regenerative medicine and tissue engineering. Innovations include the development of composite scaffolds made from polymers combined with natural substances, which improve scaffold performance and support tissue regeneration. There is also a growing emphasis on scaling up production capabilities to enable broader market access.
• Germany: Germany's progress in scaffold technology is driven by cutting-edge research on biodegradable materials and advanced manufacturing techniques. These innovations focus on creating scaffolds with enhanced mechanical properties and controlled degradation rates. Additionally, Germany is exploring the combination of scaffold treatments with other therapeutic solutions, such as gene therapy or cellular therapy, to achieve better outcomes.
• India: In India, the scaffold technology market is evolving with a focus on affordable and scalable solutions. Recent advances include the development of cost-effective yet biocompatible materials, along with the establishment of research collaborations aimed at boosting scaffold performance. Scaffold technology is also being explored to address large-scale tissue engineering challenges in clinical settings.

Features of the Global Scaffold Technology Market

Market Size Estimates: Scaffold technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Scaffold technology market size by product type, type, application, end use, and region in terms of value ($B).

Regional Analysis: Scaffold technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product type, type, application, end use, and regions for the scaffold technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the scaffold technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the scaffold technology market by product type (natural scaffold and synthetic scaffold), type (macro-porous scaffolds, micro-porous scaffolds, nano-porous scaffolds, and solid scaffolds), application (drug discovery, regenerative medicine, cancer cell research, and stem cell research), end use (biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Scaffold Technology Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Scaffold Technology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Scaffold Technology Market by Product Type
  • 3.3.1: Natural Scaffold
  • 3.3.2: Synthetic Scaffold
• 3.4: Global Scaffold Technology Market by Type
  • 3.4.1: Macro-Porous Scaffolds
  • 3.4.2: Micro-Porous Scaffolds
  • 3.4.3: Nano-Porous Scaffolds
  • 3.4.4: Solid Scaffolds
• 3.5: Global Scaffold Technology Market by Application
  • 3.5.1: Drug Discovery
  • 3.5.2: Regenerative Medicine
  • 3.5.3: Cancer Cell Research
  • 3.5.4: Stem Cell Research
• 3.6: Global Scaffold Technology Market by End Use
  • 3.6.1: Biotechnology & Pharmaceutical Companies
  • 3.6.2: Contract Research Laboratories
  • 3.6.3: Academic Institutes

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Scaffold Technology Market by Region
• 4.2: North American Scaffold Technology Market
  • 4.2.1: North American Market by Application: Drug Discovery, Regenerative Medicine, Cancer Cell Research, and Stem Cell Research
  • 4.2.2: North American Market by End Use: Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes
• 4.3: European Scaffold Technology Market
  • 4.3.1: European Market by Application: Drug Discovery, Regenerative Medicine, Cancer Cell Research, and Stem Cell Research
  • 4.3.2: European Market by End Use: Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes
• 4.4: APAC Scaffold Technology Market
  • 4.4.1: APAC Market by Application: Drug Discovery, Regenerative Medicine, Cancer Cell Research, and Stem Cell Research
  • 4.4.2: APAC Market by End Use: Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes
• 4.5: ROW Scaffold Technology Market
  • 4.5.1: ROW Market by Application: Drug Discovery, Regenerative Medicine, Cancer Cell Research, and Stem Cell Research
  • 4.5.2: ROW Market by End Use: Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Scaffold Technology Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Scaffold Technology Market by Type
  • 6.1.3: Growth Opportunities for the Global Scaffold Technology Market by Application
  • 6.1.4: Growth Opportunities for the Global Scaffold Technology Market by End Use
  • 6.1.5: Growth Opportunities for the Global Scaffold Technology Market by Region
• 6.2: Emerging Trends in the Global Scaffold Technology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Scaffold Technology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Scaffold Technology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Synthecon
• 7.2: Bico
• 7.3: Lonza
• 7.4: Thermo Fisher Scientific
• 7.5: Avantor
• 7.6: ReproCELL
• 7.7: 3D Biotek
• 7.8: Corning
• 7.9: Becton, Dickinson, &Company
• 7.10: InSphero